EDRH
PFE icon

Edmond de Rothschild Holding’s Pfizer PFE Stock Holding History

Edmond de Rothschild Holding’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-50,000
Closed -$25K – 817
2022
Q3 		$25K Buy
+50,000
New +$2.43M ﹤0.01% 732

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Edmond de Rothschild Holding's PFE Position: Q1 2026 in Review

Edmond de Rothschild Holding reduced its Pfizer (PFE) stake by 12% in Q1 2026, selling an estimated $5.73M and leaving 1,584,079 shares worth $44.5M. The position accounts for 0.64% of the portfolio, ranked #44.

Edmond de Rothschild Holding first reported a position in PFE in Q2 2015 and has held it in 44 quarters since. The position peaked at $104M in Q1 2017. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Edmond de Rothschild Holding held 1,584,079 shares of Pfizer worth $44.5M as of Q1 2026.
  • Edmond de Rothschild Holding sold 215,301 Pfizer shares in Q1 2026, an estimated $5.73M.
  • Pfizer made up 0.64% of Edmond de Rothschild Holding's portfolio in Q1 2026, its #44 holding.
  • Edmond de Rothschild Holding first reported a position in Pfizer in Q2 2015 and has held it in 44 quarters since.
  • Edmond de Rothschild Holding's Pfizer position peaked at $104M in Q1 2017.
  • 2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Edmond de Rothschild Holding's 13F filing for Q1 2026, filed 13 May 2026.